Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )
The award is presented by MaxWell Biocorporation to an internationalpublic figure or organization that has made outstanding contributions toimproving the health of under-served populations and demonstrated decisiveleadership on public health issues.
Advertisement
Mrs. Yushchenko was chosen as the first recipient of the award inrecognition of her service as Chair of the Ukraine 3000 InternationalCharitable Foundation, her efforts on behalf of Ukraine's children, and herleadership in promoting early detection and treatment of breast cancer amongUkrainian women.
"Improved medical care in Ukraine is a priority for my husband, PresidentVictor Yushchenko, and for my Foundation 'Ukraine 3000.' The health caresector in Ukraine is undergoing major change and improvement, but still needsmuch reform, investment, and training to bring it up to European standards,"Mrs. Yushchenko wrote in a May 18 letter to Dr. Alibek.
"We appreciate MaxWell Biocorporation's investments into the Ukrainianhealth care sector and its efforts to provide Ukrainians with affordable, highquality pharmaceutical products and medical services," she added.
Dr. Ken Alibek, founder, President and CEO of MaxWell Biocorporation,presented the award to Mrs. Yushchenko during the opening of the MaxWell USAsymposium "21st Century Pharmaceutical Production and Health Care Research &Delivery in the CIS." The symposium was held at the Ritz-Carlton inWashington, D.C. on May 28 (http://www.max-well.com/eng/press_whale.php).
Ukrainian Ambassador to the United States Oleh Shamshur received the awardon behalf of Mrs. Yushchenko(http://www.max-well.com/img/photogallery/picture032_1.jpg).
About MaxWell
MaxWell Biocorporation is a U.S.-based, privately-held internationalmedical and pharmaceutical company with wholly owned subsidiaries andaffiliates in the United States and Ukraine dedicated to increasing lifeexpectancy and improving the quality of life of people in Ukraine and otherunderserved emerging healthcare markets in the former Soviet Union. MaxWelltargets oncological, cardiological, chronic infectious and autoimmunedisorders and diseases through the development, production, and introductioninto clinical practice of sophisticated, high quality, and affordableoff-patent generic biopharmaceutical and chemopharmaceutical medicines and thelatest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness.""We Help You Live Longer" Contact: Alex Meerovich [email protected] 202-454-3403
SOURCE MaxWell Biocorporation
